Toyonaka, Japan

Hideaki Nagaya


Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 51(Granted Patents)


Location History:

  • Osaka, JP (1998)
  • Toyonaka, JP (2001 - 2003)

Company Filing History:


Years Active: 1998-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Hideaki Nagaya

Introduction

Hideaki Nagaya is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on condensed pyridazine derivatives. With a total of 5 patents to his name, Nagaya's inventions are aimed at addressing various allergic conditions.

Latest Patents

Nagaya's latest patents include groundbreaking developments in condensed pyridazine derivatives. One of his notable inventions is a condensed pyridazine derivative that serves as a pharmaceutical composition for preventing or treating allergic skin diseases such as contact dermatitis, pruritus, dried dermatitis, acute urticaria, and prurigo. Another significant patent focuses on condensed pyridazine compounds that exhibit anti-allergic activity, anti-histaminic activity, and eosinophil chemotaxis-inhibiting activity. These compounds are useful in preventing or treating asthma, allergic conjunctivitis, allergic rhinitis, urticaria, and atopic dermatitis.

Career Highlights

Nagaya is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to explore and develop innovative solutions for various health issues, particularly in the realm of allergy treatment.

Collaborations

Throughout his career, Nagaya has collaborated with esteemed colleagues such as Yasuhiko Kawano and Michiyo Gyoten. These collaborations have further enriched his research and development efforts, leading to impactful innovations in the pharmaceutical industry.

Conclusion

Hideaki Nagaya's contributions to the field of pharmaceuticals through his patented inventions demonstrate his commitment to improving health outcomes for individuals suffering from allergic conditions. His work continues to inspire advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…